Get access to our best features

Get access to our best features

Published 2 years ago

Has ProPhase Labs (PRPH) Outpaced Other Medical Stocks This Year?

Summary by Ground News

ProPhase Labs, Inc. (PRPH) is one of 1184 individual stocks in the Medical sector. Collectively, these companies sit at #8 in the Zacks Sector Rank. The Zacks Consensus Estimate for PRPH's full-year earnings has moved 107.6% higher within the past quarter.

0 Articles

0 Articles

All

Left

Center

Right

Zacks Investment Research

Has ProPhase Labs (PRPH) Outpaced Other Medical Stocks This Year?

Here is how ProPhase Labs, Inc. (PRPH) and RVL Pharmaceuticals PLC (RVLP) have performed compared to their sector so far this year.

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.

Coverage Details

Total News Sources0

Leaning Left0Leaning Right0Center0Last Updated2 years agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics

Stories disproportionately reported by the Left or the Right

Similar News Topics

Trending Topics

Donate Privacy Policy Manage Cookies Terms and Conditions

© 2024 Snapwise Inc.